Table 4.
Association between serum albumin levels and cancer mortality in specific cancer types.
| Groups | N | Cancer mortality (Per 1g/dL albumin decrease) | ||||
|---|---|---|---|---|---|---|
| Crude HR (95% CI) |
P
for trend |
Adjusted HR (95% CI) |
P
for trend |
|||
| Skin (non-melanoma) | 694 | 2.97 (1.89, 4.69) | < 0.01 | 2.50 (1.51, 4.13) | < 0.01 | |
| Prostate | 667 | 1.95 (1.33, 2.86) | < 0.01 | 1.35 (1.12, 2.04) | < 0.01 | |
| Breast | 643 | 2.65 (1.72, 4.09) | < 0.01 | 1.96 (1.22, 3.08) | < 0.01 | |
| Skin (others) | 344 | 2.33 (1.29, 4.20) | < 0.01 | 2.40 (1.24, 4.64) | < 0.01 | |
| Colon | 273 | 2.43 (1.53, 3.87) | < 0.01 | 1.80 (1.04, 3.12) | < 0.01 | |
| Melanoma | 263 | 5.26 (3.03, 8.92) | < 0.01 | 2.63 (1.37, 5.07) | < 0.01 | |
| Lung | 102 | 3.57 (1.72, 7.35) | < 0.01 | 3.45 (1.38, 8.69) | < 0.01 | |
Crude model: adjusted for none. Adjusted model: adjusted for age, sex, ethnicity, BMI, smoking, drinking, hypertension, diabetes mellitus, anemia, CVD. HR, Hazard ratio and CI, confidence interval.